President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Digital backbone: Unpacking the data centre explosion with Clyde & Co | Commercial Awareness Compass #38
The Commercial Awareness Compass by AllAboutLaw
29 minutes
4 months ago
Digital backbone: Unpacking the data centre explosion with Clyde & Co | Commercial Awareness Compass #38
From uninterrupted power supplies to rigorous cooling requirements and airtight security measures, data centre deals have never been more complex. This episode explores the legal strategies that underpin one of Britain’s fastest‑growing industries. More about Clyde & Co: Clyde & Co is a global law firm providing a complete service to clients in its core sectors of insurance, transport, energy, infrastructure and trade & commodities. We’re growing and transforming our business and ...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
